Anti-KIAA0652/ATG13 antibody [EPR19601]
- RabMAb
- Recombinant
- What is this?
Be the first to review this product! Submit a review
|
(10 Publications)
Rabbit Recombinant Monoclonal KIAA0652/ATG13 antibody. Suitable for IP, WB, Flow Cyt (Intra) and reacts with Human, Mouse, Rat samples. Cited in 10 publications.
View Alternative Names
KIAA0652, ATG13, Autophagy-related protein 13
- Flow Cyt (Intra)
Unknown
Flow Cytometry (Intracellular) - Anti-KIAA0652/ATG13 antibody [EPR19601] (AB201467)
Intracellular flow cytometric analysis of 4% paraformaldehyde-fixed HeLa (Human epithelial cell line from cervix adenocarcinoma) cells labeling KIAA0652/ATG13 with ab201467 at 1/60 dilution (red) compared with a rabbit monoclonal IgG isotype control (ab172730; black) and an unlabelled control (cells without incubation with primary antibody and secondary antibody; blue). Goat Anti-Rabbit IgG (Alexa Fluorr® 488) at 1/2000 dilution was used as the secondary antibody.
- IP
Unknown
Immunoprecipitation - Anti-KIAA0652/ATG13 antibody [EPR19601] (AB201467)
KIAA0652/ATG13 was immunoprecipitated from 0.35 mg of HeLa (Human epithelial cell line from cervix adenocarcinoma) whole cell lysate with ab201467 at 1/30 dilution. Western blot was performed from the immunoprecipitate using ab201467 at 1/1000 dilution. VeriBlot for IP Detection Reagent (HRP) (ab131366), was used for detection at 1/10000 dilution.
Lane 1 : HeLa whole cell lysate 10μg (Input).
Lane 2 : ab201467 IP in HeLa whole cell lysate.
Lane 3 : Rabbit monoclonal IgG (ab172730) instead of ab201467 in HeLa whole cell lysate.
Blocking and dilution buffer and concentration : 5% NFDM/TBST.
Exposure time : 30 seconds.
All lanes:
Immunoprecipitation - Anti-KIAA0652/ATG13 antibody [EPR19601] (ab201467)
Predicted band size: 56 kDa
false
- WB
Supplier Data
Western blot - Anti-KIAA0652/ATG13 antibody [EPR19601] (AB201467)
Blocking/Dilution buffer : 5% NFDM/TBST.
All lanes:
Western blot - Anti-KIAA0652/ATG13 antibody [EPR19601] (ab201467) at 1/1000 dilution
Lane 1:
Human cerebellum lysate at 20 µg
Lane 2:
Human hippocampus lysate at 10 µg
Secondary
All lanes:
Goat Anti-Rabbit IgG Peroxidase Conjugate, specific to the non-reduced form of IgG at 1/10000 dilution
Predicted band size: 56 kDa
Observed band size: 70 kDa
false
Exposure time: 3min
- WB
Supplier Data
Western blot - Anti-KIAA0652/ATG13 antibody [EPR19601] (AB201467)
Blocking/Dilution buffer : 5% NFDM/TBST.
All lanes:
Western blot - Anti-KIAA0652/ATG13 antibody [EPR19601] (ab201467) at 1/1000 dilution
Lane 1:
HeLa (Human epithelial cell line from cervix adenocarcinoma) cytoplasmic fraction lysate at 10 µg
Lane 2:
HeLa (Human epithelial cell line from cervix adenocarcinoma) nuclear fraction lysate at 10 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution
Predicted band size: 56 kDa
Observed band size: 70 kDa
false
Exposure time: 15s
- WB
Supplier Data
Western blot - Anti-KIAA0652/ATG13 antibody [EPR19601] (AB201467)
Blocking/Dilution buffer : 5% NFDM/TBST.
Exposure times : Lane 1-3 : 30 seconds; Lane 4 : 3 minutes.
The molecular weight observed is consistent with what has been described in the literature (PMID : 18936157).
All lanes:
Western blot - Anti-KIAA0652/ATG13 antibody [EPR19601] (ab201467) at 1/1000 dilution
Lane 1:
HeLa (Human epithelial cell line from cervix adenocarcinoma) whole cell lysate at 20 µg
Lane 2:
MCF7 (Human breast adenocarcinoma cell line) whole cell lysate at 20 µg
Lane 3:
A20 (Mouse reticulum sarcoma cell line) whole cell lysate at 20 µg
Lane 4:
A-673 (Human muscle Ewing's Sarcoma cell line) whole cell lysate at 10 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution
Predicted band size: 56 kDa
Observed band size: 70 kDa
false
- WB
Supplier Data
Western blot - Anti-KIAA0652/ATG13 antibody [EPR19601] (AB201467)
Blocking/Dilution buffer : 5% NFDM/TBST.
All lanes:
Western blot - Anti-KIAA0652/ATG13 antibody [EPR19601] (ab201467) at 1/1000 dilution
Lane 1:
C6 (Rat glial tumor cell line) whole cell lysate at 10 µg
Lane 2:
RAW 264.7 (Mouse macrophage cell line transformed with Abelson murine leukemia virus) whole cell lysate at 10 µg
Lane 3:
PC-12 (Rat adrenal gland pheochromocytoma cell line) whole cell lysate at 10 µg
Lane 4:
NIH/3T3 (Mouse embryonic fibroblast cell line) whole cell lysate at 10 µg
Lane 5:
Mouse brain tissue lysate at 10 µg
Lane 6:
Rat brain tissue lysate at 10 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution
Predicted band size: 56 kDa
Observed band size: 70 kDa
false
Exposure time: 3min
Reactivity data
Product details
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (10)
Recent publications for all applications. Explore the full list and refine your search
Frontiers in molecular neuroscience 16:1170313 PubMed37138705
2023
Applications
Unspecified application
Species
Unspecified reactive species
International journal of molecular sciences 23: PubMed35008820
2021
Applications
Unspecified application
Species
Unspecified reactive species
EMBO reports 22:e51136 PubMed34369648
2021
Applications
Unspecified application
Species
Unspecified reactive species
Scientific reports 11:14898 PubMed34290273
2021
Applications
Unspecified application
Species
Unspecified reactive species
Nature 589:456-461 PubMed33328639
2020
Applications
Unspecified application
Species
Unspecified reactive species
Nature methods 17:232-239 PubMed31768061
2019
Applications
Unspecified application
Species
Unspecified reactive species
Experimental and therapeutic medicine 18:2574-2582 PubMed31555366
2019
Applications
Unspecified application
Species
Unspecified reactive species
Molecular medicine reports 19:3519-3526 PubMed30896869
2019
Applications
Unspecified application
Species
Unspecified reactive species
International journal of molecular medicine 41:2086-2098 PubMed29344647
2018
Applications
Unspecified application
Species
Unspecified reactive species
Cell death & disease 7:e2563 PubMed28032867
2016
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com